| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 17th, 2005 | 18 | No |
Popular Name: 1,4-Diaminoanthraquinone 1,4-Diaminoanthraquinone
Find On: PubMed — Wikipedia — Google
CAS Numbers: 128-95-0 , [128-95-0]
"1,4-Diaminoanthraquinone, 90%"
1,4-diamino-9,10-dihydroanthracene-9,10-dione
1,4-Diaminoanthracene-9,10-dione
1,4-Diaminoanthraquinone, tech. 90%
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 2.54 | 3.77 | -8.26 | 4 | 4 | 0 | 86 | 238.246 | 0 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Melting_Point | 260-265? | Alfa-Aesar |
| Melting_Point | 260-265° | Alfa-Aesar |
| MP | 264 - 266 | Enamine Building Blocks |
| MP | 264...266 | Enamine Building Blocks |
| MP | 265 - 269 | Enamine Building Blocks |
| MP | 270 | TCI |
| purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
| Purity | 95% | Fluorochem |
| Purity | 97% | APIChem |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AA2AR-2-E | Adenosine A2a Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 320 | 0.51 | Binding ≤ 10μM |
| DYR1A-1-E | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1A (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3600 | 0.42 | Binding ≤ 10μM |
| HIPK2-1-E | Homeodomain-interacting Protein Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3300 | 0.43 | Binding ≤ 10μM |
| KC1A-1-E | Casein Kinase I Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.42 | Binding ≤ 10μM |
| KC1D-1-E | Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 330 | 0.50 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AA2AR_HUMAN | P29274 | Adenosine A2a Receptor, Human | 320 | 0.51 | Binding ≤ 1μM |
| KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 330 | 0.50 | Binding ≤ 1μM |
| AA2AR_HUMAN | P29274 | Adenosine A2a Receptor, Human | 320 | 0.51 | Binding ≤ 10μM |
| KC1A_HUMAN | P48729 | Casein Kinase I Alpha, Human | 4000 | 0.42 | Binding ≤ 10μM |
| KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 330 | 0.50 | Binding ≤ 10μM |
| DYR1A_HUMAN | Q13627 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 1A, Human | 3600 | 0.42 | Binding ≤ 10μM |
| HIPK2_HUMAN | Q9H2X6 | Homeodomain-interacting Protein Kinase 2, Human | 3300 | 0.43 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| Adenosine P1 receptors | |
| APC truncation mutants have impaired AXIN binding | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| Circadian Clock | |
| Degradation of beta-catenin by the destruction complex | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| G alpha (s) signalling events | |
| G0 and Early G1 | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| NGF-independant TRKA activation | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Regulation of PLK1 Activity at G2/M Transition | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| truncations of AMER1 destabilize the destruction complex |
No pre-computed analogs available. Try a structural similarity search.